BRD is one of the most severe and costly diseases in the livestock industry. Infection is caused by a number of pathogens and can be fatal if left untreated. Every instance of BRD leads to a drastic reduction in profits due to losses in productivity. Resilient Biotics is developing non-antibiotic, precision microbial therapeutics to prevent and treat BRD.
Resilient currently has a number of live microbial therapeutics that have been lab validated against dominant BRD pathogens.
Resilient BRD Therapeutic
Live microbiome therapeutic
Compatible with normal cattle processing